They are a breakthrough, says Fabrizio Schifano, a psychiatrist at the University of Hertfordshire in England and co-author of the study
In a 48-week clinical trial, higher doses consistently led to greater average weight loss: Weight loss by dose (48-week clinical trial) In this trial, at the highest dose (12 mg), people lost an average 24% of their starting weight on average
doi: 10.1007/s00198-014-2908-x
Its using carefully calibrated amounts of medications like semaglutide and tirzepatide (the active pharmaceutical ingredient found in Ozempic, Wegovy, Mounjaro, and Zepbound) that may support metabolic function, reduce inflammation, and promote cardiovascular health without substantial weight change
Table of Contents What Are Retatrutide and Tesamorelin
PMID 12183643